Literature DB >> 9874489

Dendritic cells enhance the differentiation of naïve B cells into plasma cells in vitro.

J Fayette1, I Durand, J M Bridon, C Arpin, B Dubois, C Caux, Y J Liu, J Banchereau, F Brière.   

Abstract

We have shown previously that in vitro-generated human dendritic cells have an effect on the response of B cells at various stages of their differentiation. In a culture system described for the in vitro induction of plasma-cell differentiation, it was reported that naïve B cells have a poor propensity to differentiate into plasma cells. In such a culture system, 12% of naïve B cells differentiated into plasma cells in the presence of IL-2 and IL-10, despite the interruption of CD40 signalling which is necessary for plasma-cell differentiation. However, as reported herein, naïve B cells differentiated fully into plasma cells in response to dendritic cells. Addition of dendritic cells enhanced this differentiation strikingly by recruiting 57% of B cells as plasma cells producing IgM, but also IgG and IgA. In this model, dendritic cells act in synergy with IL-2 at an early stage of CD40-dependent B-cell differentiation, while IL-2 and IL-10 act together, at a later stage, in the generation of plasma cells in a CD40-independent manner. Thus, in addition to the key role played by dendritic cells in the initiation of T-cell responses, our results suggest that dendritic cells regulate humoral responses.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9874489     DOI: 10.1046/j.1365-3083.1998.00471.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  21 in total

Review 1.  Controlling immune responses by targeting antigens to dendritic cell subsets and B cells.

Authors:  Craig P Chappell; Natalia V Giltiay; Christiane Dresch; Edward A Clark
Journal:  Int Immunol       Date:  2013-11-27       Impact factor: 4.823

Review 2.  Heterogeneity of Memory Marginal Zone B Cells.

Authors:  Jacobus Hendricks; Nicolaas A Bos; Frans G M Kroese
Journal:  Crit Rev Immunol       Date:  2018       Impact factor: 2.214

3.  Roles of major histocompatibility complex class II in inducing protective immune responses to influenza vaccination.

Authors:  Eunju O; Young-Tae Lee; Eun-Ju Ko; Ki-Hye Kim; Yu-Na Lee; Jae-Min Song; Young-Man Kwon; Min-Chul Kim; Daniel R Perez; Sang-Moo Kang
Journal:  J Virol       Date:  2014-04-23       Impact factor: 5.103

4.  Cytosolic DNA-activated human dendritic cells are potent activators of the adaptive immune response.

Authors:  Katalin Kis-Toth; Attila Szanto; To-Ha Thai; George C Tsokos
Journal:  J Immunol       Date:  2011-06-27       Impact factor: 5.422

5.  Optimal long-term humoral responses to replication-defective herpes simplex virus require CD21/CD35 complement receptor expression on stromal cells.

Authors:  Mark A Brockman; Admar Verschoor; Jia Zhu; Michael C Carroll; David M Knipe
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

6.  CD28 expressed on malignant plasma cells induces a prosurvival and immunosuppressive microenvironment.

Authors:  Jayakumar R Nair; Louise M Carlson; Chandana Koorella; Cheryl H Rozanski; Gerald E Byrne; P Leif Bergsagel; John P Shaughnessy; Lawrence H Boise; Asher Chanan-Khan; Kelvin P Lee
Journal:  J Immunol       Date:  2011-06-29       Impact factor: 5.422

7.  Development of murine lupus involves the combined genetic contribution of the SLAM and FcgammaR intervals within the Nba2 autoimmune susceptibility locus.

Authors:  Trine N Jørgensen; Jennifer Alfaro; Hilda L Enriquez; Chao Jiang; William M Loo; Stephanie Atencio; Melanie R Gubbels Bupp; Christina M Mailloux; Troy Metzger; Shannon Flannery; Stephen J Rozzo; Brian L Kotzin; Mario Rosemblatt; María Rosa Bono; Loren D Erickson
Journal:  J Immunol       Date:  2009-12-16       Impact factor: 5.422

Review 8.  Cytokines in systemic lupus erythematosus.

Authors:  Elaine V Lourenço; Antonio La Cava
Journal:  Curr Mol Med       Date:  2009-04       Impact factor: 2.222

9.  The early protective thymus-independent antibody response to foot-and-mouth disease virus is mediated by splenic CD9+ B lymphocytes.

Authors:  Matias Ostrowski; Monica Vermeulen; Osvaldo Zabal; Patricia I Zamorano; Ana M Sadir; Jorge R Geffner; Osvaldo J Lopez
Journal:  J Virol       Date:  2007-06-13       Impact factor: 5.103

Review 10.  Gene-modified dendritic cells for immunotherapy against cancer.

Authors:  Andreas Lundqvist; Pavel Pisa
Journal:  Med Oncol       Date:  2002       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.